Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lukert B. Glucocorticoid‐induced osteoporosis. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press, 1996;801–13.
Reid IR. Gluco‐corticoid‐induced osteoporosis and other forms of secondary osteoporosis. In: Meunier PJ, ed. Osteoporosis: diagnosis and management. London: Martin Dunitz, 1998:233–50.
Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax1991;46:803–6.
Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis1995;54:49–52.
Lems WF, Jahangier ZN, Jacobs JWG, Bulsma JWJ. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol1995; 13:293–7.
McDougall R, Sibley J, Haga M, Russell A. Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol1994;21: 1207–13.
Saag KG, Koehnke R, Caldwell JR, et al. Low dose long‐term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events. Am J Med1994; 96:115–23.
Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: An evaluation of associated risk factors. J Rheumatol1993;20:1666–9.
Laan RFJM, van Riel PLCM, van Erning LJTO, Lemmens JAM, Ruijs SHJ, van de Putte LBA. Vertebral osteoporosis in rheumatoid arthritis patients: Effect of low dose prednisone therapy. Br J Rheumatol1992;31:91–6.
Butler RC, Davie MWJ, Worsfold M, Sharp CA. Bone mineral content in patients with rheumatoid arthritis: Relationship to low‐dose steroid therapy. Br J Rheumatol1991;30:86–90.
Michel BA, Bloch DA, Fries JF. Predictors of fractures in early rheumatoid arthritis. J Rheumatol1991;18:804–9.
Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD. Osteoporosis in rheumatoid arthritis: safety in low dose corticosteroids. Ann Rheum Dis1986;45:950–3.
Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis1986;45:852–7.
Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid‐induced osteopenia in patients with rheumatic diseases. Arthritis Rheum1985;28:361–8.
Hooyman JR, Melton JL IIII, Nelson AM, O'Fallon MW, Riggs BL. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum1984;27:1353–61.
Adinoff AD, Hollister MD, Roger J. Steroid‐induced fractures and bone loss in patients with asthma. New Engl J Med1983;309:265–8.
Saville PD, Oved K. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum1967;10:423–31.
McConkey B, Fraser GM, Bligh AS. Osteoporosis and purpura in rheumatoid disease: Prevalence and relation to treatment with corticosteroids. Q J Med, New Series XXXI1962;124:419–27.
Van Staa TP, Leufkens B, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res2000;15:993–1000.
Hall G. Pharmacoepidemiology using a UK Database of Primary Care Records. Pharmacoepidemiol Drug Safety1992;1:33–7.
Lis Y, Mann RD. The Vamp Research Multi‐purpose Database in the U.K. J Clin Epidemiol1995;48:431–43.
Mann RD, Hall G, Chukwujindu J. Research implications of computerised primary care. Post Marketing Surveillance1992;5:259–68.
Hollowell J. General Practice Research Database (GPRD): Scope and quality of data. London: Office of Population Censuses and Statistics, 1994.
Anonymous. The general practice research database: information for researchers. London: Office for National Statistics, 1996.
Jick H, Jick SS, Derby LE. Validation of Information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J1991;302: 766–8.
Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Safety1992;1:347–9.
Nazareth I, King M, Haines A, Rangel L, Myers S. Accuracy of diagnosis of psychosis on general practice computer system. Br Med J1993;307:32–4.
Van Staa TP, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety1994;3:15–21.
British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary Number 32 (September 1996). Wallingford, UK: Pharmaceutical Press, 1996.
Breslow NE, Day NE. Statistical methods in cancer research. Lyon: International Agency for Research on Cancer, 1987.
Greenland S. Dose–response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology1995;6:356–65.
Pizer M. Numerical Computing and Mathematical Analysis. Chicago: Science Research Associates, 1975. Chapter 4, pp. 251–456.
SAS/GRAPH Software: Reference, Version 6, First Edition, Vol. 1. Cary, NC: SAS Institute,1996.
Dequeker J, Westhovens R. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: Bones of contention. J Rheumatol1995;22:1013–9.
Cooper C. Osteoporosis in rheumatological practice: questions to be answered. Ann Rheum Dis1995;54:1–2.
Henderson NK, Sambrook PN. Relationship between osteoporosis and arthritis and effect of corticosteroids and other drugs on bone. Curr Opin Rheumatol1996; 8:365–9.
Eastell R, Reid DM, Compston J, et al. A UK consensus group on management of glucocorticoid induced osteoporosis: an update. J Intern Med1998;244:271–92.
van Staa TP, Abenheim L, Cooper C, Zhang B, Leufkens HGM. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Safety 2001; in press.